Wellness Industry News: GMP Complaint Against Confidence USA, Crown Labs Expands Again, More
Executive Summary
FDA seeks injunction against Confidence USA; Crown Labs expands again; CHPA, PCPC say Environmental Working Group "irresponsibly misrepresents” evidence on sunscreen safety; Kratom Information & Resource Center says 92% of news about kratom published since February was ‘unfair and unbalanced’; more news.
You may also be interested in...
In Order Shutting Down New York Supplement Firm, Federal Judge Also Criticizes FDA’s Calculations
Judge ordering permanent injunction against Confidence USA on a complaint filed in 2019 questioned FDA's calculations for requiring the firm to recall and destroy all products it had distributed since February 2018.
HBW Market News: FTC Targets Bone Health Claims, Puration Offers To Buy Hemp4mula, More
FTC settled with one firm and is pursuing litigation against another after alleging claimed supplements could grow bone and cartilage; CBD beverage firm Puration offers to acquire Hemp4mula; and Huron Capital’s Ronnoco Beverage business acquires Trident Beverage.
Opioid Abuse Treatment Claims Prompt FDA Warnings To Two Kratom Marketers
As in previous warnings to kratom supplement marketers linked to opioid addiction treatment claims, FDA tells Cali Botanicals and Kratom NC that HHS in 2017 found opioid abuse was nationwide public health emergency and FDA is targeting products that without approval claim to diagnose, mitigate, prevent, treat or cure opioid addiction. Contract manufacturer Somlabs' GMP problems also were identified in FDA's latest warning letters.